Showing results (171-180 of 196) with videos related to
Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older menBu B Yeap, Helman Alfonso, S A Paul Chubb, et al.Endocrine Connections|July 31, 2023
Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension studyYee-Ming M Cheung, Rudolf Hoermann, Karen Van, et al.Clinical Chemistry and Laboratory Medicine|October 2, 2024
Establishing the TSH reference intervals for healthy adults aged over 70 years: the Australian ASPREE cohort studyCammie Tran, Duncan J Topliss, Hans G Schneider, et al.The Journal of Clinical Endocrinology and Metabolism|February 10, 2025
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) TrialGary A Wittert, Kristy P Robledo, David J Handelsman, et al.European Journal of Endocrinology|January 10, 2022
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injectionsDavid J Handelsman, Reena Desai, Ann J Conway, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled TrialSabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann, et al.The Journal of Clinical Endocrinology and Metabolism|January 3, 2019
Selective Loss of Levator Ani and Leg Muscle Volumes in Men Undergoing Androgen Deprivation TherapyAda S Cheung, Christopher Cunningham, Dong-Kyoon Daniel Ko, et al.Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up StudyDavid J Handelsman, Mathis Grossmann, Bu B Yeap, et al.Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.Pageof 20